The phenotypic changes of microglia in brain diseases are particularly diverse and their role in disease progression, beneficial, or detrimental, is still elusive. High-throughput molecular approaches such as single-cell RNA-sequencing can now resolve the high heterogeneity in microglia population for a specific physiological condition, however, 
| INTRODUCTION
Microglia, the resident immune cells of the central nervous system (CNS), are not only at the frontline of brain defense mechanisms (Ramirez-Exposito & Martinez-Martos, 1998 ) but also adopt diverse functions during CNS development in the establishment of neuronal circuitry, synaptic plasticity, and brain maintenance. However, in certain conditions, their activation may be maladaptive, detrimental to neurons, and promote neurodegeneration (Ayata et al., 2018; Hansen, Hanson, & Sheng, 2018) . The spectrum of microglia functionalities is reflected by a large phenotypic diversity that has been recently highlighted by highthroughput RNA sequencing of dissociated single cells from mouse models or human brain samples. Their heterogeneity can be influenced by the physiological or pathological context (Friedman et al., 2018; Mathys et al., 2017) including species specificity, neurological disease states, and regional distribution (Galatro et al., 2017; Gosselin et al., 2017; Grabert et al., 2016; Soreq et al., 2017; Sousa, Biber, & Michelucci, 2017) . While single cell RNA sequencing gives a comprehensive molecular characterization of a population of cells, it does not provide the spatial information that is required to fully understand mechanisms of brain homeostasis and disease progression. Changes in the molecular program of microglia and corresponding morphological transformations serve as a read-out of microglial functional changes and their ability to interact within brain microenvironments (Bachstetter et al., 2015;  Fernández-Arjona, Grondona, Granados-Durán (Chung et al., 2013; Grabow, Yoder, & Mote, 2000; Hama et al., 2015; Ke, Fujimoto, & Imai, 2013; Lai et al., 2018) . A few recent
corresponding computational approaches exist to analyze 3D morphologies (Falk et al., 2019; Heindl et al., 2018) Figure S1 ) that captures morphological heterogeneity of microglia at single cell level in large 3D high-resolution confocal stacks from mouse and human brain sections immunolabeled for cell-type specific morphological markers.
| MATERIALS AND METHODS

| Human brain samples
All experiments involving human tissues were conducted in accordance with the guidelines approved by the Ethics Board of the 
| Immunohistochemistry
Immunostaining was performed as previously described (Bouvier et al., 2016; Quesseveur, Fouquier d'Hérouël, Murai, & Bouvier, 2019) with the modification that human brain sections were first irradiated with an ultraviolet lamp (Ushio, 30 W) for 18-24 hr in PBS solution to reduce residual autofluorescence background. In brief, 50 μm thick brain sections were rinsed three times for 10 min in PBS followed by a 30-min permeabilization step with 0.3% Triton-X 100 in PBS. Subsequently, free-floating sections were incubated for 2 hr with blocking solution (0.3% Triton-X 100 and 2% horse serum in PBS), followed by incuba- 
| Image preprocessing
To decrease staining variation caused by the thickness of the slices and background noise in the confocal data, each stack was submitted to the "normalize layers" and "background subtraction" (500 μm) tools from Imaris 9.0 (Bitplane). Shot noise was alleviated with a 3D median filter of size 2 × 2 × 2 voxels using Fiji (https://fiji.sc). 
| Iterative image segmentation
| Feature extraction
In order to examine the morphological properties of the extracted 3D structures, we implemented a new method for capturing the intrinsic complexity of their morphologies by two sets of features. First, the so-called graph-based features were obtained using an underlying graph defined by nodes that comprise regions of the cell where projections split and edges that describe node connections. This information is captured by the adjacency matrix A where a ij = 1 if nodes i and j are connected or a ij = 0 otherwise, and by the weighting matrix W where w ij can take any positive value describing the length of the edge connecting node i and j. For the graph construction, we first used an established skeletonization method (Kerschnitzki et al., 2013) to create a 3D array S of 0 s and 1 s where 1 indicates voxels that shape the skeleton. On this skeleton, we then run Algorithm 2 ( Figure S3 ) that computes the matrices A and W. From these matrices, we subsequently derived all graph-based measures by functions contained in the Octave Networks Toolbox (Bounova, 2015) .
Second, we obtained a set of features capturing geometrical properties of the structures. To compute these, a central node was defined for each structure by predicting the location of the cell nucleus. This estimation used a subset of graphical features of each node including the degree (number of other nodes connected to the measured one), betweenness (centrality measure that accounts for the number of the shortest paths between two other nodes that cross the current node), closeness (inverse sum of the distance of the node to all other nodes in the network), and eccentricity (maximum distance to any other nodes).
Particularly, the central node is defined as the one that has maximum values for the first three features and minimal eccentricity. If several nodes equally satisfied this criterion, we chose the one with the maximum value of betweenness and of closeness if there is still more than one. The obtained central node was used for the computation of further geometrical features such as sphericity or polarity. Additionally, we considered other geometrical properties such as the volume or the lengths of the bounding box (Table S1 ). After extraction and combination of these two types of features, each individual structure is characterized by a set of D = 62 features as described in Table S1 . For a total of N structures, we therefore obtain a feature matrix F with dimensions N × D. All methodologies described in this section can be run through the MIC-MAC "Feature Extraction" GUI ( Figure S1 ).
| Dimensionality reduction and cluster analysis
To facilitate subsequent processing, we first reduced the number of structures, that is, the number of rows in matrix F, by filtering the first set of artifacts with a volume below 180 μm 3 leading to a reduced fea- 
we then apply cluster analysis by using k-means (Lloyd, 1982) . First, the number of clusters is estimated by knee-plot analysis that depicts the mean squared fitting error (within-cluster sum) over the number of clusters k. The considered heuristic criteria choose k as the minimum number of clusters that lies to the right of the "knee," but is not yet in the plateau region ( Figure S4 ) and justified by posterior visual validation.
After defining k, we run k-means repeatedly and assigned each structure to a cluster by majority voting to increase the robustness of structure classification. All steps described above can be executed through the MIC-MAC "Dimensionality reduction and Clustering" GUI ( Figure S1 ).
| Validation of data
After k-means clustering, we plot random subsets of 3D renders for each cluster using the tool "Plot 3D renders" of the MIC-MAC "Analysis" GUI ( Figure S1 ). This allows the visual inspection of the homogeneity of the cluster and testing if the cluster assembles real cells or grouped artifacts caused by immunostaining background or the segmentation process. Additionally, by using the "Generate overlays for validation" tool of the MIC-MAC "Analysis" GUI, we automatically generated images that can be overlaid onto the original image of these structures in a cluster-specific color-coded manner to further support the validation of the selected clusters. After the visual inspection, clusters containing artifacts were removed from the database. Furthermore, using the median volume of these artifactual structures as reference, a new minimum volume threshold for valid structures of 260 μm 3 was defined.
Subsequently, dimensionality reduction was rerun leading to a new reduced feature matrix F Trf , and followed by further cluster analysis on these transformed data. This iterative process can be repeated until the clusters are validated as homogenous groups of in silico structures accurately representing Iba1+ cells in the tissue.
| Statistical comparison
Given the cluster assignments, we compared different samples and conditions in terms of cluster prevalence. In order to normalize this measure, that is, the number of structures per sample and cluster, we 
| Similarity plot
To visualize how different clusters relate to each other in terms of morphological characteristics, we implemented a similarity analysis. First, for a specific cluster c, we computed the median values for each feature of all structures assigned to c from the reduced feature matrix F Trf . This led to a vector f c of length D 0 for each of the identified clusters. Based on these vectors, we computed a similarity matrix between clusters using the Euclidean distance. After defining a threshold of 50% for the maximal distance, we finally obtained the similarity plot. This plot indicates morphology changes between clusters, and their interrelations.
Additionally, we used the vector f c to find the prototypical structures that described the median shape of the objects assigned to cluster c by computing the Euclidean distance of all structures in cluster c to the vector f c , and then plotted those with the smallest distances. Both tools are called from the "Prototypical & Similarity plot" option of the MIC-MAC "Analysis" GUI.
| Morphological feature ranking
While the PCA transformed features support fast classification and similarity analysis, it can be interesting to identify most discriminating original features for the various morphologies grouped into different clusters.
For ranking the features, we implemented Algorithm 3 ( Figure S5 ) that provides a list of the most important features in descending order which was used to select most relevant features to visualize.
| Implementation
MIC-MAC is implemented in MATLAB and each step of the pipeline can be controlled by a graphical user interface (GUI) enabling also noncomputational scientist to perform high-throughput analyses. The workflow ( Figure S1 ) starts with the segmentation process for which the user chooses the original imaging data and the previously generated Ilastik mask to be loaded into the GUI. The provided segmentation algorithm is using a single CPU to enable the usage without any high-performance computing (HPC) structure but due to the typically large imaging data, we have also implemented a HPC version (see the MIC-MAC webpage https://micmac.lcsb.uni.lu for more details). After segmentation, the Feature Extraction GUI allows to select the (DLB; n = 3) patients, and from age-matched control (n = 3) subjects (Section 2; Table 1 ). These samples were immunostained for ionized calcium binding adaptor molecule 1 (Iba1), a commonly used morphological marker for microglia and immune cells, and large volumes were imaged by high-resolution confocal microscopy.
In the brain, microglia form a dense branching network and manual and automatic segmentation of 3D samples is challenging due to overlapping and adjacent complex microglial subcellular structures. Figure S2 ). This approach preserves the core structure of microglia, extracts finer geometrical details and segmented successfully over 99% of Iba1+ cells after six iterations in all samples (Figure 2 , Movie S1).
MIC-MAC resolves this issue by
Each in silico reconstruction of a microglial cell is then registered in a library with its spatial coordinates and its erosion-corrected volume.
| MIC-MAC classifies microglia based on 62 geometrical and graph-based features by cluster analysis
For classification of the resulting 3D in silico structures, MIC-MAC automatically extracts a set of morphological features based on (a) geometrical characteristics directly determined from the segmented shapes such as volume, polarity, and compactness but also from (b) graph-based properties such as node degree, centrality, and diameter determined from graph representations of each structure generated by skeletonization of Iba1+ cells (Algorithm 2 in Figure S3 ). The resulting 62 morphological features (Table S1 ) captured even subtle characteristics of each reconstruction such as arborization complexity. After 
| Microglia and immune brain cells diversity in mouse and human, in health and disease
The relevance of studying microglia functions in brain diseases and neurodegeneration is now well established (Bouvier & Murai, 2015; Sousa et al., 2017) . However, due to their heterogenous population, the protective or neurotoxic role of microglia is still controversially discussed (Salter & Stevens, 2017) . Single-cell RNA sequencing studies have highlighted microglia phenotypic diversity in different conditions (Gonçalves et al., 2010; Sousa et al., 2018) , identified regional and species differences and disease-specific expression signatures but parenchyma. At this stage, we have no indication that this humanspecific microglia morphology is associated with a peculiar function (Friedman et al., 2018; Galatro et al., 2017; Gosselin et al., 2017; Smith & Dragunow, 2014) . Our analysis of the morphology of Iba1+ cells in human samples also revealed more drastic changes in AD than in DLB when compared to age-matched control. In particular, the number of cells associated with cluster 1 formed by smaller amoeboid structures is found significantly increased in AD. Although we applied MIC-MAC to a relatively small number of samples, the highthroughput analysis with more than 10,000 cells allowed us obtaining significant differences between species and conditions despite interindividual variability. To further substantiate our findings including the trends for AD samples (Figure 7b ) and for a more comprehensive comparison between AD and DLB conditions, a larger number of analyzed samples reflecting different severity stages would be beneficial.
From the present data, we can only extrapolate that microglia may react differently to the distinct pathological inclusions found in the brain parenchyma. Indeed, microglia are known to react with strong functional changes to extracellular amyloid plaques (Keren-Shaul et al., 2017) but less is known about their response to Lewy bodies.
In conclusion, MIC-MAC upgrades morphological analyses of microglia in situ to an unprecedented level of detail and resolution.
MIC-MAC can unveil new sets of data that will help to characterize microglia functions in brain disease progression and can serve as an efficient tool of postmortem diagnostic of microglia changes, in mouse models and human brain autopsy samples. Ultimately MIC-MAC will support the future characterization of how morphologies of microglia correlated with their functions.
